Circulating Tumor DNA As a Marker of Recurrence Risk in Stage III Colorectal Cancer: the Α-Correct Study.

Brenda Diergaarde, Greg Young,David W. Hall, Amin Mazloom, Gina L. Costa, Soma Subramaniam,Melanie R. Palomares, Jorge Garces,Frederick L. Baehner,Robert E. Schoen, xact Sciences MRD Group

JOURNAL OF SURGICAL ONCOLOGY（2025）

Cited 0|Views3

Key words

colorectal cancer,ctDNA,molecular residual disease (MRD),tumor-informed

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined